Skip to main content

Our Chief Business Officer Savita Bernal attended HYBRID 2021, on March 16th, an event focused this year on Immunology and Inflammatory Disorders. Savita shared with the audience a presentation entitled « Diversity Matters :  MaaT Pharma’s Microbiome Ecosystem Therapies in Graft-vs-Host-Disease and Oncology».

See the full video down below.

Leave a Reply